Spectrum Pharmaceuticals, Inc.
(NASDAQ : SPPI)

( )
SPPI PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson 0.19%163.530.7%$1333.35m
LLYEli Lilly & Co. 0.74%323.991.1%$1075.80m
ABBVAbbVie, Inc. 0.94%139.601.9%$860.15m
PFEPfizer Inc. 0.48%44.320.9%$801.41m
BMYBristol-Myers Squibb Co. -0.01%70.531.0%$772.67m
MRKMerck & Co., Inc. 0.46%87.960.7%$713.70m
AZNAstraZeneca Plc 1.48%56.371.0%$393.21m
ALNYAlnylam Pharmaceuticals, Inc. 0.00%196.798.2%$217.39m
GSKGSK Plc 1.69%30.740.3%$213.05m
NVSNovartis AG 1.67%77.950.2%$205.02m
ATXIAvenue Therapeutics, Inc. 42.66%16.420.0%$198.73m
GBTGlobal Blood Therapeutics, Inc. 0.00%68.485.4%$191.16m
IDXXIDEXX Laboratories, Inc. 1.10%340.393.9%$186.31m
HZNPHorizon Therapeutics Plc 0.00%64.265.4%$173.65m
SRPTSarepta Therapeutics, Inc. 0.00%109.9412.4%$136.73m

Company Profile

Spectrum Pharmaceuticals, Inc. is a biotechnology company, which engages in the acquisition, development and commercialization of a pipeline of novel and targeted oncology therapies. Its product pipeline includes: Eflapegrastim, Poziotinib, and IGN002. The company was founded in December 1987 and is headquartered in Henderson, NV.